000 01324nam a2200325 a 4500
005 20250930101008.0
008 981208s1970 us 00 eng d
039 9 _a201602051225
_bhendon
_y08-18-1999
_zload
090 _aWL359.L113 1969 9 [00009002821]
090 _aWL359
_b.L113 1969 9
245 1 0 _aL-dopa and Parkinsonism /
_cedited by Andre Barbeau and Fletcher H. McDowell.
260 _aPhiladelphia :
_bDavis,
_c1970.
300 _a433 p. :
_bill. ;
_c26 cm.
500 _aIncludes bibliographical references.
500 _aBased on an International Conference held in Quebec, November 9th-11th, 1969 and supported in part by the National Institute of Neurological Diseases and Stroke
650 _aDopa
_vCongresses.
650 _aDOPA
_xPharmacodynamics
_vCongresses.
650 _aDOPA
_xToxicity
_vCongresses.
650 _aParkinsonism
_vCongresses.
650 _aParkinsonism
_xDrug therapy
_vCongresses.
700 1 _aBarbeau, Andre.
700 1 _aMcDowell, Fletcher H.,
_d1923-
_940742
700 2 _aNational Institute of Neurological Diseases and Stroke
907 _a.b11254336
_b2021-05-28
_c2019-11-12
942 _c01
_n0
_kWL359.L113 1969 9 [00009002821]
914 _avtls000130195
991 _aFakulti Perubatan
998 _ad
_b1999-05-08
_cm
_da
_feng
_g
_y0
_z.b11254336
999 _c127183
_d127183